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The fasting level of free fatty acids and sugar in plasma and their response to subcutaneous epinephrine administration was studied in
children suffering from congenital heart disease. In cyanotic cases elevated fasting values were found for free fatty acids (14 cases); in
non-cyanotics, however, the values were normal (7 cases). In non-cyanotic heart disease the rise of free fatty acids and sugar in response
to epinephrine administered subcutaneously was normal, while in cyanotic patients (10 cases) it was found to be decreased. When the
studies were repeated with intravenous infusion of epinephrine the cyanotic patients showed a normal response.
Der Nüchternspiegel von freien Fettsäuren und Glucose im Plasma sowie deren Reaktion auf subcutane Adrenalinapplikation wurde bei
Kindern mit angeborenen Herzfehlern untersucht. Bei Herzfehlern mit Cyanose wurden erhöhte Nüchternwerte für freie Fettsäuren ge-
funden (n = 14), während sie bei solchen ohne Cyanose normal waren (n = 7). Der Anstieg von freien Fettsäuren und Glucose nach
subcutaner Adrenalinapplikation war bei den Kranken ohne Cyanose normal, während er bei denen mit Cyanose (n = 10) vermindert
war. Bei Wiederholung der Versuche mit intravenöser Adrenalininfusion zeigten auch die cyanotischen eine normale Reaktion.
In cyanotic congenital heart disease glycolysis shifts
towards anaerobiosis as seen from the elevation of the
lactic acid level (1). The fasting level of blood sugar and
the carbohydrate tolerance after peroral administration
of sugar are normal (2). Up to the present no investiga-
tion has been made of the metabolism of free fatty acids.
In dogs the free fatty acid level rises during acute
hypoxia and this is most probably due to an increased
catecholamine production (3). A high level of free fatty
acids was also found in the umbilical artery of hypoxic
newborn infants (4). The present work deals with the
fasting level of free fatty acids and its release provoked
by epinephrine in children with congenital heart
disease.
Methods
Examinations were carried out on children of 2—14 years of age
suffering from congenital heart disease and on healthy children of
the same age. The patients were divided into two groups: heart
disease with cyanosis (right to left shunt) and without cyanosis
(left to right shunt). Patients with heart failure and those receiving
drugs were not included. The blood was taken after overnight
fasting. The investigations with epinephrine were performed
6 hours after meal. 0.03mg/kg, max. 0.5mg epinephrine was
administered subcutaneously and the blood samples were taken
at 0, 30, 60, 90 and 120 minutes. Intravenously, 2^g/kg/min
epinephrine was infused for 30 minutes and the blood was ob-
tained at 0, 15, 30 and 60 minutes. The free fatty acid deter-
mination was carried out by DOLE'S (5) and in some cases by
ANSTALL'S method (6). The sugar was estimated by the method of
SOMOGYI-NELSON.
Results
The fasting level of sugar is normal in all types of heart
disease. The free fatty acids are normal in noncyanotic
patients (table 1). In children with cyanosis the free fatty
acid level is higher than in healthy children or patients
exhibiting no cyanosis (p < 0,01). Since in hypoxia the
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levels of lactic acid and other organic acids are elevated
in the blood and this might cause falsely high values for
free fatty acids by DOLE'S method, we repeated the ex-
aminations with ANSTALL'S colorimetric method which
is more specific for free fatty acids. High free fatty acid
levels could be found with this method as well. There
was no correlation between the haemoglobin and the
free fatty acid concentration.
In further examinations we studied the changes of
plasma free fatty acids and sugar after subcutaneous ad-
ministration of epinephrine (table 2). In cases with left
to right shunt the response was similar to that of healthy
children, while in right to left shunt the rise was smaller
in respect to both free fatty acids and glucose. Since the
reduced release of free fatty acids and sugar might be
caused by the slower absorption of epinephrine if ad-
ministered subcutaneously, we repeated the measure-
ments in some cases after the intravenous infusion of
epinephrine (table 3). In three cases out of four we found
the mobilisation of free fatty acids and sugar normal, so
it can thus be assumed that in cyanotic patients the
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Tab. 2
Change of plasma free fatty acids and sugar in response to epinephrine administered subcutaneously. Mean values
n Change of plasma free fatty acids (^Val//) Change of plasma sugar mg/100 ml
































Free fatty acid and sugar levels in response to epinephrine administered intravenously
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slower absorption of epinephrine may be partially or
wholly responsible for the reduced release of free fatty
acids and sugar.
Discussion
Enhanced lipolysis may be one of the possible explana-
tions for the high plasma free fatty acids found in
cyanotic cases of congenital heart disease. The studies
with epinephrine show that in these patients the ability
of adipose tissue to release free fatty acids is not im
paired, consequently the possibility of increased lipolysis
cannot be excluded. In hypoxia the catecholamine level
increases (7) which causes a high level of free fatty acids.
This was found e. g. in phaeochromocytoma as a con-
sequence of high catecholamine secretion (8). In cya-
notic patients, however, the excretion of catecholamine
metabolites in the urine increases only slightly (9), it
thus seems improbable that the great increase in the free
fatty acid level should be solely due to the mobilisation
of catecholamines. There have been no studies carried
out concerning the other hormones (growth hormone,
thyroxin, glucocorticoids) influencing the free fatty
acid release.
The other possible explanation is that the reesterifica-
tion of free fatty acids into triglycerids is decreased. It
is noteworthy in this respect that HAIT and Coworkers
found an increased insulin secretion in patients with
cyanotic heart disease (2). If the high level of free fatty
acids and insulin can really be found simultaneously it
can be assumed that the adipose tissue in these patients
is resistant to insulin. The measurement of plasma
glycerol can provide further information on whether the
high level of free fatty acids is due to increased lipolysis
or decreased reesterification, since the whole quantity
of glycerol released from the adipose tissue gets into the
circulation, whereas a certain amount of free fatty acids
is immediatly reesterificated.
Finally it can be assumed that in these patients the peri-
pheral utilisation of free fatty acids is reduced and this
might also be an explanation for the high plasma free
fatty acids.
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